XML 88 R72.htm IDEA: XBRL DOCUMENT v3.24.0.1
Events after the Reporting Period (Details)
 1 Months Ended 6 Months Ended 12 Months Ended
Oct. 11, 2023
USD ($)
$ / shares
shares
Aug. 14, 2023
USD ($)
shares
Mar. 22, 2023
Nov. 01, 2022
shares
Sep. 15, 2022
shares
Aug. 02, 2022
shares
Mar. 10, 2022
USD ($)
Jul. 21, 2021
shares
Oct. 01, 2020
shares
Aug. 18, 2023
$ / shares
shares
Mar. 23, 2020
$ / shares
Jun. 30, 2023
USD ($)
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Jun. 30, 2023
ILS (₪)
Events after the Reporting Period (Details) [Line Items]                              
Description of public offering   the Company closed an underwritten public offering (the “Public Offering”) of 212,500 ordinary shares, at a purchase price of $5.20 per ordinary share and pre-funded warrants to purchase up to 37,500 ordinary shares at a purchase price of $5.174 per pre-funded warrant, for aggregate gross proceeds of approximately $1.3 million, pursuant to an underwriting agreement between the Company and Aegis Capital Corp (“Aegis”), the underwriter in the Public Offering, dated August 10, 2023. Pursuant to the terms of the underwriting agreement, the Company also granted the underwriter a 45-day option to purchase up to an additional 37,500 ordinary shares solely to cover over-allotments, if any, at the share price of the Public Offering less underwriting discounts and commissions.                          
Warrants and exercise | $   $ 26.000                     $ 3,000 $ 4,758,000 [1]  
Shares issued (in Shares) | shares                         6,798,840 3,091,740  
Exercise of pre-funded warrants (in Shares) | shares                         3,211,100    
Ordinary shares issued (in Shares) | shares       37,000 75,000,000 24,000   6,000 40 75,000,000          
Purchase of ordinary share (in Shares) | shares                       247,415      
Exercise price (in Dollars per share) | $ / shares                     $ 24.5   $ 24.5 $ 24.5  
Cash | ₪                             ₪ 2,500,000
Additional agreed invest | $             $ 1,000,000                
Monthly fee | $                         $ 20,000    
Bonus amount | $                         51,000    
Ordinary shares value | $                         288,238,000    
Aggregate value | $                       $ 288,238,000 288,238,000    
Adjusted amount of aggregate value | $                         $ 300,000,000    
Ownership percentage                         4.99%    
MitoCareX [Member]                              
Events after the Reporting Period (Details) [Line Items]                              
Percentage of stock equal                         49.00%    
Additional agreed invest | $                         $ 489,330,000    
Percentage of working capital     51.00%                        
Jeffs’ Brands [Member]                              
Events after the Reporting Period (Details) [Line Items]                              
Purchase of ordinary share (in Shares) | shares                       13,858      
Cash | $                         $ 2,500,000    
Adjusted amount of aggregate value | $                       $ 300,000,000      
MitoCare X Bio Ltd [Member]                              
Events after the Reporting Period (Details) [Line Items]                              
Ownership agreement             50.01%           5.00%    
SCISPARC LTD [Member]                              
Events after the Reporting Period (Details) [Line Items]                              
Shares issued (in Shares) | shares   25,000                     360,297    
Exercise of pre-funded warrants (in Shares) | shares   25,000                          
Jeffs’ Brands [Member]                              
Events after the Reporting Period (Details) [Line Items]                              
Shares issued (in Shares) | shares                         247,415    
Subsequent [Member]                              
Events after the Reporting Period (Details) [Line Items]                              
Ordinary shares issued (in Shares) | shares                   75,000,000          
Ordinary shares par value (in Dollars per share) | $ / shares                            
Aggregate gross proceeds | $ $ 5,000,000                            
Percentage of aggregate purchase price 30.00%                            
Aggregate purchase price | $ $ 7,180,000                            
Purchase price per share (in Dollars per share) | $ / shares $ 3.72                            
Pre-funded ordinary share (in Shares) | shares 1,930,108                            
Purchase of ordinary share (in Shares) | shares 1,930,108                            
Purchase ordinary shares (in Shares) | shares 1,930,108                            
Term of issuance 5 years                            
Exercise price (in Dollars per share) | $ / shares $ 0.001                            
[1] Net of issue expenses of $358